# A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

> **NCT02995720** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 60 (actual)

## Conditions studied

- Hypertension, Hyperlipidemia

## Interventions

- **DRUG:** Fimasartan/Amlodipine combination drug, Rosuvastatin

## Key facts

- **NCT ID:** NCT02995720
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-26
- **Primary completion:** 2016-11-10
- **Final completion:** 2017-05-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995720, "A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02995720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*